Gavreto
Roche, Blueprint’s RET cancer drug Gavreto cleared in EU
Phil Taylor
Blueprint Medicines, Eli Lilly, EU, Gavreto, Oncology, regulatory approval, RET inhibitor, Retevmo, Roche
0 Comment
X
Roche, Blueprint’s RET cancer drug Gavreto cleared in EU
https://pharmaphorum.com/news/roche-blueprints-ret-cancer-drug-gavreto-cleared-in-eu/
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Phil Taylor
Blueprint Medicines, Gavreto, imaging, Oncology, Retevmo, Roche, thyroid cancer
0 Comment
X
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
https://pharmaphorum.com/news/roche-blueprint-raise-pressure-on-lilly-with-new-gavreto-approval/